{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-141335","form_type":"8-K","ticker":null,"cik":"0001779020","company_name":"Danimer Scientific, Inc.","filed_at":"2024-12-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.576532+00:00","generated_at":"2026-05-28T21:57:29.946542+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Danimer Scientific gets NYSE delisting notice; common stock to trade on OTCQX","bullets":["NYSE notified Danimer on Dec 30 of delisting for failing to maintain avg global market cap ≥ $15M over 30 days.","Trading on NYSE suspended after Dec 30 close; common stock expected to trade on OTCQX under DNMR from Dec 31.","Company assessing appeal; if no appeal, delisting effective 10 days after NYSE files Form 25 with SEC.","Delisting does not affect business operations or SEC reporting obligations.","Warrants (DNMRW) continue trading on OTCQX."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-141335","json":"https://secwatch.observer/filing/0000950170-24-141335.json","markdown":"https://secwatch.observer/filing/0000950170-24-141335.md","text":"https://secwatch.observer/filing/0000950170-24-141335.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/0000950170-24-141335-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/dnmr-20241230.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T21:57:29.946542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7a8ab5d97381daff20fd826316a9fa8ce536f34e","claim":"Danimer Scientific, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).","evidence_excerpt":"December 30, 2024, the New York Stock Exchange (“NYSE”) notified Danimer Scientific Inc. (“Danimer” or the “Company”) that it has determined to commence proceedings to delist the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), as a result of the Company’s non-compliance with Rule 802.01B of the NYSE Listed Company Manual that requires listing companies to maintain an average global market capitalization of at least $15 million over a period of 30 consecutive trading days. Trading in the Common Stock on the NYSE was suspended after market close on December 30","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024141335/0000950170-24-141335-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"802.01B"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}